Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022260

Expand all

VELETRI (EPOPROSTENOL SODIUM)
EQ 0.5MG BASE/VIAL Marketing Status: Prescription

Active Ingredient: EPOPROSTENOL SODIUM
Proprietary Name: VELETRI
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.5MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022260
Product Number: 002
Approval Date: Jun 28, 2012
Applicant Holder Full Name: ACTELION PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

VELETRI (EPOPROSTENOL SODIUM)
EQ 1.5MG BASE/VIAL Marketing Status: Prescription

Active Ingredient: EPOPROSTENOL SODIUM
Proprietary Name: VELETRI
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.5MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022260
Product Number: 001
Approval Date: Jun 27, 2008
Applicant Holder Full Name: ACTELION PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English